MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…
  • 2016 International Congress

    LRRK2, MAPT and HTRA2 mutations in the pedigree of familial neurodegenerative parkinsonism with cognitive deterioration spanning five generations in a genetically isolated population of south-eastern Moravia, Czech Republic

    T. Bartonikova, R. Vodicka, K. Mensikova, R. Vrtel, P. Kanovsky, P. Otruba, M. Vastik, L. Mikulicova, S. Kurcova, P. Jugas, J. Ovecka, L. Sachova, F. Dvorsky (Olomouc, Czech Republic)

    Objective: To obtain genetic information about the individuals with confirmed parkinsonism in an isolated rural region in south-eastern Moravia, Czech Republic. Background: An epidemiological study…
  • 2016 International Congress

    Understanding, predicting, and preventing falls in progressive supranuclear palsy

    B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)

    Objective: To (1) evaluate which factors are associated with increasing falls in Progressive Supranuclear Palsy (PSP), unrelated to freezing; and (2) subsequently develop a predictive…
  • 2016 International Congress

    Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

    K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

    Objective: To evaluate the relationship between fatigue and sleep disturbances in patients with Parkinson's disease (PD). Background: In patients with PD, fatigue is an important…
  • 2016 International Congress

    The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

    S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)

    Objective: We investigated the relationship between olfactory impairment, REM sleep behavior disorders (RBD), initial cognitive performance and motor phenotype in Parkinson's disease (PD). Background: Olfactory…
  • 2016 International Congress

    Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results

    E. Bayram, M.C. Akbostanci (Ankara, Turkey)

    Objective: To investigate verb naming differences in hypokinetic (Parkinson's disease, PD) and hyperkinetic (primary cervical dystonia, PCD) movement disorders; and to determine whether different effects…
  • 2016 International Congress

    Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

    K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

    Objective: To address the co-occurrence of the burden of non-motor symptoms staging (NMSB) and motor severity of Parkinson's disease (PD) using the Hoehn and Yahr…
  • 2016 International Congress

    Barriers to providing quality care for people with Parkinson’s living in care homes in the UK: The role of staff training

    L.L. Oates, A. Hand, R.W. Walker, W.K. Gray (North Shields, United Kingdom)

    Objective: To explore the models of training delivery and interaction between Parkinson's disease nurse specialists (PDNS), Parkinson's UK (PUK) and care home staff (CHS) when…
  • 2016 International Congress

    Types of farming and prevalence and incidence of Parkinson’s disease: French nationwide study

    S. Kab, J. Spinosi, L. Chaperon, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Elbaz (Saint-Maurice, France)

    Objective: We used types of farming as a proxy for pesticide exposure and investigated its association with Parkinson's disease (PD) prevalence/incidence in the entire French…
  • 2016 International Congress

    Recognition of parkinsonism in African Americans in a community-based sample

    D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

    Objective: To investigate recognition of parkinsonism in African Americans (AA) in a community-based sample in Chicago. Background: Prior studies suggest that the manifestation of parkinsonism…
  • « Previous Page
  • 1
  • …
  • 331
  • 332
  • 333
  • 334
  • 335
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley